A carregar...

Safety and efficacy of bone marrow-derived autologous CD133(+) stem cell therapy

The Phase I clinical study was designed to assess the safety and feasibility of a dose escalating intracoronary infusion of autologous bone marrow (BM)-derived CD133+ stem cell therapy to the patients with chronic total occlusion (CTO) and ischemia. Nine patients were received CD133+ cells into epic...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Adler, Dale S., Lazarus, Hillard, Nair, Ravi, Goldberg, Jonathan L., Greco, Nicholas J., Lassar, Tom, Laughlin, Mary J., Das, Hiranmoy, Pompili, Vincent J.
Formato: Artigo
Idioma:Inglês
Publicado em: 2011
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3285247/
https://ncbi.nlm.nih.gov/pubmed/21196330
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!